Sign in
Groups
Researchers
Funding
Results
ICCRAM-Environment, Sustainability and Toxicology
ICCRAM-EST
Instituto de Salud Carlos III
Madrid, España
You are in
Collaborations
Instituto de Salud Carlos III
Publications in collaboration with researchers from Instituto de Salud Carlos III (1)
2022
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma
Cancers, Vol. 14, Núm. 4
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de